hesperetin has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Z; Li, L; Liu, F; Lu, F; Qu, L; Wang, W | 1 |
| Baluchnejadmojarad, T; Khalili, M; Kiasalari, Z; Roghani, M | 1 |
2 other study(ies) available for hesperetin and Parkinson Disease
| Article | Year |
|---|---|
Citrus Flavonoid Hesperetin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Reduces Their Cytotoxicity: In Vitro and In Vivo Studies.
Topics: alpha-Synuclein; Amyloid; Flavonoids; Hesperidin; Humans; Parkinson Disease | 2023 |
Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
Topics: Administration, Oral; Animals; Apoptosis; Corpus Striatum; Glial Fibrillary Acidic Protein; Gliosis; Hesperidin; Male; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats, Wistar | 2016 |